The halt will remain in place until the opening of trade on Monday 8th May 2017, or earlier if an announcement is made to the market.
View full AC8 profile View Profile
September 12 2018
August 31 2018
August 30 2018
July 05 2018
AusCann Group's vertically integrated model provides point of difference in medicinal cannabis indus
March 24 2018
Control of the supply chain offers operational advantages and financial benefits.
June 25 2018
Cosmos is a modern company, but the trade routes it relies on are ancient
August 02 2018
Currently undergoing phase III clinical trials, AP101 is being developed to treat Epidermolysis Bullosa, a condition which occurs prominently in children and makes skin fragile to even the faintest touch